Home / Nervous system / Selegiline
ATC N04BD01 · Monoamine Oxidase B Inhibitors
Selegiline shortage
As of 2 Nov 2026, Selegiline has a reported shortage in 1 of the 15 countries we track (Canada), covering 1 product from 1 company.
Countries1/15
Products1packs or presentations
Companies11 listed
Short since20 Jan 20206.8 years ago
Earliest returnnot givencompany estimate
Main reasonManufacturing problem
United StatesNo reported shortageCanada1 product shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageAustraliaNo reported shortage
Timeline
Canada
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Teva TEVA · NYSE / TASE
Compared with similar medicines
ATC group N04BD · Monoamine Oxidase B InhibitorsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | TEVA-SELEGILINE (60) | TEVA CANADA LIMITED | 20 Jan 2020 | not given | Manufacturing problem Disruption of the manufacture of the drug |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.